Literature DB >> 4364382

Fibrosis as in indication of time in infiltrating breast cancer and its importance in prognosis.

O T Anastassiades, D M Pryce.   

Abstract

The histological grading of tumours according to their intrinsic malignancy is very important in the prognosis of breast cancer but within each grade the ultimate prognosis depends mainly on the age of the tumours.We have shown that tumour fibrosis is an indication of this time factor, increasing with the age of the tumour. Within each grade the metastatic ratio is higher and the 5 year and 10 year survival less with the scirrhous than with the non-scirrhous tumours. The establishment of axillary metastases is closely connected with both the degree of malignancy and the time available, the unfavourable effect upon survival being greater in the scirrhous than in the non-scirrhous tumours.Another consequence of the passage of time, as indicated by fibrosis, is the gradual diminution of lymphoid infiltration (LI) which is mostly present in young tumours, especially those of high grades. The favourable effect of LI upon survival is demonstrated in the non-scirrhous tumours of grade III, possibly because of its great intensity, but this influence upon survival is lost as fibrosis increases and the intensity of the reaction diminishes.

Entities:  

Mesh:

Year:  1974        PMID: 4364382      PMCID: PMC2009096          DOI: 10.1038/bjc.1974.62

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  Early phases in the development of breast cancer.

Authors:  H S Gallager; J E Martin
Journal:  Cancer       Date:  1969-12       Impact factor: 6.860

2.  Further observations on prognostic factors in cancer of the female breast.

Authors:  S J Cutler; M M Black; T Mork; S Harvei; C Freeman
Journal:  Cancer       Date:  1969-10       Impact factor: 6.860

3.  Prognostic significance of pathologic findings in human breast carcinoma.

Authors:  J R Bell; G H Friedell; I S Goldenberg
Journal:  Surg Gynecol Obstet       Date:  1969-08

4.  Human breast carcinoma. II. Research potential.

Authors:  M M Black
Journal:  N Y State J Med       Date:  1970-04-15

5.  Therapeutic implications from a mathematical model characterizing the course of breast cancer.

Authors:  N H Slack; L E Blumenson; I D Bross
Journal:  Cancer       Date:  1969-11       Impact factor: 6.860

6.  Prognostic factors in cancer of the female breast. II. Reproducibility of histopathologic classification.

Authors:  S J Cutler; M M Black; G H Friedell; R A Vidone; I S Goldenberg
Journal:  Cancer       Date:  1966-01       Impact factor: 6.860

7.  Host resistance and survival in carcinoma of breast: a study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years.

Authors:  H J Bloom; W W Richardson; J R Field
Journal:  Br Med J       Date:  1970-07-25

8.  Histological grading in breast cancer.

Authors:  I C Tough; D C Carter; J Fraser; J Bruce
Journal:  Br J Cancer       Date:  1969-06       Impact factor: 7.640

9.  Possible host resistance in carcinoma of the breast: a histological study.

Authors:  I M Hamlin
Journal:  Br J Cancer       Date:  1968-09       Impact factor: 7.640

10.  Histological grading in carcinoma of the breast.

Authors:  B Wolff
Journal:  Br J Cancer       Date:  1966-03       Impact factor: 7.640

View more
  12 in total

1.  Identification of T and B lymphocytes in human breast cancer with immunohistochemical techniques.

Authors:  R Schoorl; A B Riviere; A E Borne; T M Feltkamp-Vroom
Journal:  Am J Pathol       Date:  1976-09       Impact factor: 4.307

Review 2.  Matrix metalloproteinase inhibitors in the treatment of cancer.

Authors:  P D Brown
Journal:  Med Oncol       Date:  1997-03       Impact factor: 3.064

3.  Loss of one Tgfbr2 allele in fibroblasts promotes metastasis in MMTV: polyoma middle T transgenic and transplant mouse models of mammary tumor progression.

Authors:  Wei Bin Fang; Iman Jokar; Anna Chytil; Harold L Moses; Ty Abel; Nikki Cheng
Journal:  Clin Exp Metastasis       Date:  2011-03-04       Impact factor: 5.150

4.  Matricellular proteins in cancer: a focus on secreted Frizzled-related proteins.

Authors:  Krista Marie Vincent; Lynne-Marie Postovit
Journal:  J Cell Commun Signal       Date:  2017-06-07       Impact factor: 5.782

5.  Long-Standing Scirrhous Breast Carcinoma en Cuirasse.

Authors:  Alexis Lacout; Pierre Yves Marcy; Guy Lesec
Journal:  Breast Care (Basel)       Date:  2010-10-15       Impact factor: 2.860

6.  Elevated expression of chemokine C-C ligand 2 in stroma is associated with recurrent basal-like breast cancers.

Authors:  Min Yao; Elaine Yu; Vincent Staggs; Fang Fan; Nikki Cheng
Journal:  Mod Pathol       Date:  2016-04-29       Impact factor: 7.842

Review 7.  Liquid-based three-dimensional tumor models for cancer research and drug discovery.

Authors:  Stephanie L Ham; Ramila Joshi; Pradip S Thakuri; Hossein Tavana
Journal:  Exp Biol Med (Maywood)       Date:  2016-04-11

8.  Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters.

Authors:  Alexandra Naba; Karl R Clauser; John M Lamar; Steven A Carr; Richard O Hynes
Journal:  Elife       Date:  2014-03-11       Impact factor: 8.140

9.  Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins.

Authors:  An Zou; Diana Lambert; Henry Yeh; Ken Yasukawa; Fariba Behbod; Fang Fan; Nikki Cheng
Journal:  BMC Cancer       Date:  2014-10-24       Impact factor: 4.430

10.  Mitogen-activated protein kinase signaling causes malignant melanoma cells to differentially alter extracellular matrix biosynthesis to promote cell survival.

Authors:  Anna Afasizheva; Alexus Devine; Heather Tillman; King Leung Fung; Wilfred D Vieira; Benjamin H Blehm; Yorihisa Kotobuki; Ben Busby; Emily I Chen; Kandice Tanner
Journal:  BMC Cancer       Date:  2016-03-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.